Display options
Cite
Parker WH, Moudgil R, Wilson RG, et al. COVID-19 and postural tachycardia syndrome: a case series. Eur Heart J Case Rep. 2021;5(12):ytab325doi: 10.1093/ehjcr/ytab325.
Parker, W. H., Moudgil, R., Wilson, R. G., Tonelli, A. R., Mayuga, K. A., & Singh, T. K. (2021). COVID-19 and postural tachycardia syndrome: a case series. European heart journal. Case reports, 5(12), ytab325. https://doi.org/10.1093/ehjcr/ytab325
Parker, William H, et al. "COVID-19 and postural tachycardia syndrome: a case series." European heart journal. Case reports vol. 5,12 (2021): ytab325. doi: https://doi.org/10.1093/ehjcr/ytab325
Parker WH, Moudgil R, Wilson RG, Tonelli AR, Mayuga KA, Singh TK. COVID-19 and postural tachycardia syndrome: a case series. Eur Heart J Case Rep. 2021 Dec 30;5(12):ytab325. doi: 10.1093/ehjcr/ytab325. eCollection 2021 Dec. PMID: 34993394; PMCID: PMC8716749.
Copy Download .nbib Format: NLM
Share it on

Eur Heart J Case Rep. 2021 Dec 30;5(12):ytab325. doi: 10.1093/ehjcr/ytab325. eCollection 2021 Dec.

COVID-19 and postural tachycardia syndrome: a case series.

European heart journal. Case reports

William H Parker, Rohit Moudgil, Robert G Wilson, Adriano R Tonelli, Kenneth A Mayuga, Tamanna K Singh

Affiliations

  1. Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, 9500 Euclid Ave, Desk J2-4, Cleveland, OH 44195, USA.
  2. Neuromuscular Center, Neurology Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, USA.
  3. Department of Pulmonary and Critical Care Medicine, Respiratory Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, USA.

PMID: 34993394 PMCID: PMC8716749 DOI: 10.1093/ehjcr/ytab325

Abstract

BACKGROUND: Postural tachycardia syndrome (PTS) is a novel identified sequela of COVID-19 infection. This observational study describes clinical presentation, testing, and treatment response in seven patients diagnosed with PTS following COVID-19 infection.

CASE SUMMARY: A total of seven active patients (three collegiate athletes, one recreational athlete, two registered nurses, one hospitality employee), age 24 ± 6 years, and six females were followed for a mean of 152 ± 105 days after contracting COVID-19. Tilt table was performed to establish the diagnosis. The most common presenting symptoms were palpitations (7/7), dyspnoea (6/7), and gastrointestinal complaints (5/7). One patient required hospitalization for symptom management. The mean latency of PTS onset following COVID-19 was 21 ± 15 days. Electrocardiograms (ECGs) demonstrated sinus rhythm in all patients, one with resting sinus tachycardia. Echocardiogram demonstrated normal systolic and diastolic left ventricular function in all patients. On tilt table testing, baseline heart rate (HR) was 72 ± 12 with maximum HR reaching 136 ± 13. Six of seven patients failed to respond to supportive therapy alone, and two patients failed medical management with ivabradine, midodrine, and/or metoprolol. Of three severely symptomatic patients, two demonstrated some degree of clinical recovery with intravenous immunoglobulin (IVIG).

DISCUSSION: This novel case series describes the development of PTS in the context of COVID-19 infection. Severity of symptoms and response to treatment was heterogeneous. Interestingly, patients were poorly responsive to traditional PTS treatments, but IVIG showed potential as a possible therapeutic strategy for refractory PTS in two patients, particularly following COVID-19 infection.

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Keywords: Autonomic dysfunction; Case series; Intravenous immunoglobulin; Postural tachycardia syndrome; Severe acute respiratory syndrome coronavirus 2019 (COVID-19)

References

  1. Clin Auton Res. 2020 Dec;30(6):571-573 - PubMed
  2. Am J Ther. 2019 Sep/Oct;26(5):570-582 - PubMed
  3. Clin Auton Res. 2020 Oct;30(5):449-451 - PubMed
  4. Neurology. 1993 Jan;43(1):132-7 - PubMed
  5. J Intern Med. 2019 Oct;286(4):438-448 - PubMed
  6. Can J Neurol Sci. 2005 May;32(2):264 - PubMed
  7. Heart Rhythm. 2021 Apr;18(4):508-509 - PubMed
  8. J Innov Card Rhythm Manag. 2020 Nov 15;11(11):4302-4304 - PubMed
  9. Ther Adv Neurol Disord. 2018 Jan 08;11:1756285617744484 - PubMed
  10. JACC Case Rep. 2021 Apr;3(4):573-580 - PubMed
  11. Mayo Clin Proc. 2018 Aug;93(8):1043-1053 - PubMed
  12. Pediatrics. 2017 Apr;139(4): - PubMed
  13. Nat Med. 2021 Apr;27(4):601-615 - PubMed
  14. JAMA. 2020 Oct 13;324(14):1381-1383 - PubMed

Publication Types